# Evaluation of the Effect of Cordycepin on CD8+ Lymphocytopenia in Patients With Solid Tumors

> **NCT07258160** · PHASE2 · RECRUITING · sponsor: **Second Affiliated Hospital of Soochow University** · enrollment: 127 (estimated)

## Conditions studied

- Solid Cancer
- Lymphopenia

## Interventions

- **DRUG:** PRaG-1
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07258160
- **Lead sponsor:** Second Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-01
- **Primary completion:** 2026-07
- **Final completion:** 2026-09
- **Target enrollment:** 127 (ESTIMATED)
- **Last updated:** 2026-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07258160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07258160, "Evaluation of the Effect of Cordycepin on CD8+ Lymphocytopenia in Patients With Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07258160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*